Related Experiment Video
Updated: Jul 7, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Atrial fibrillation following device closure of patent foramen ovale
Annika Burow1, Markus Schwerzmann, Dieter Wallmann
1Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland.
Insights
Atrial fibrillation (AF) occurs frequently in stroke patients after patent foramen ovale (PFO) device closure, similar to stroke patients without PFO. Further research is needed on AF risks post-PFO closure.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Recurrent embolic events post-patent foramen ovale (PFO) device closure are often attributed to incomplete closure.
- Atrial fibrillation (AF) is another potential cause of embolic events in these patients.
Purpose of the Study:
- To investigate the incidence of atrial fibrillation (AF) in patients experiencing stroke after PFO device closure.
Main Methods:
- A comparative study involving 40 patients who underwent PFO device closure post-stroke and 70 control stroke patients.
- Both groups underwent 7-day event loop recordings at 3 and 6 months post-procedure/stroke.
Main Results:
- Atrial fibrillation (AF) was detected in 15% of the PFO device closure group and 17% of the control group (p = 0.77).
- Multivariate analysis indicated that the presence of an occluder device was not an independent risk factor for AF.
Conclusions:
- The incidence of AF following PFO device closure in stroke patients is comparable to stroke patients without PFO.
- Further investigation is necessary to ascertain the thromboembolic risk and optimal management strategies for patients who develop AF after PFO device closure.
Objectives:
Recurrent embolic events after device closure of patent foramen ovale (PFO) have been related to incomplete closure. Another cause could be atrial fibrillation (AF). The aim of this study was to determine the incidence of AF in stroke patients after PFO closure.
Methods:
Consecutive patients with device closure of a PFO after a stroke or transient ischemic attack and control patients with stroke underwent 7-day event loop recordings 3 and 6 months after PFO closure or stroke, respectively.
Results:
Forty patients treated by PFO device closure 96 +/- 68 days after cryptogenic ischemic stroke and 70 control patients with ischemic stroke of other etiologies (known AF excluded) were compared. AF was identified in 6 patients (15%) of the treated group and in 12 control patients (17%, p = 0.77). In multivariate analysis, the presence of an occluder device was not an independent risk factor for AF.
Conclusions:
The incidence of AF is high after device closure of a PFO in stroke patients and similar to that in patients with stroke of non-PFO etiology and, hence, with no device. Further studies are required to determine the risk of thromboembolism and the optimal treatment in patients developing AF after device closure of a PFO.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Stenosis I: Introduction
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mitral Stenosis III: Medical Management

